Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interferon beta drives therapy resistance in a patient-derived model of high-grade serous ovarian cancer.

Molecular oncology·2026
Same author

Multi-Omics Analysis Reveals Chronic Cisplatin Exposure Is Associated with Metabolic Rewiring Toward Glutathione Metabolism to Support Redox Adaptation in High-Grade Serous Ovarian Cancer.

Cancers·2026
Same author

A novel hyperactive <i>BCR::ABL1</i> <sup><i>e6a3</i></sup> variant confers resistance to combined asciminib plus ponatinib therapy.

medRxiv : the preprint server for health sciences·2026
Same author

Efficient Generation of Functional TCRαβ<sup>+</sup> Cytotoxic T Cells from hiPSCs via Small-Molecule Modulation.

bioRxiv : the preprint server for biology·2026
Same author

Soluble Notch agonist enables human ameloblast maturation and enamel-like tissue formation for tooth regeneration.

International journal of oral science·2026
Same author

Bnip3lb-driven mitophagy maintains fate of the embryonic hematopoietic stem cell pool.

Nature communications·2026

Related Experiment Video

Updated: May 31, 2026

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells
08:52

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells

Published on: June 13, 2018

Induced pluripotent stem cells for modelling human diseases.

Juli J Unternaehrer1, George Q Daley

  • 1Stem Cell Transplantation Program, Division of Pediatric Hematology/Oncology, Children's Hospital Boston, Boston, MA 02115, USA.

Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
|July 6, 2011
PubMed
Summary

Human induced pluripotent stem (iPS) cells offer powerful models for studying diseases in vitro. Further refinement of iPS cell differentiation and drug discovery strategies are needed for effective cell-based therapies.

More Related Videos

Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery
12:40

Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery

Published on: May 19, 2018

Generation of Human Cardiomyocytes: A Differentiation Protocol from Feeder-free Human Induced Pluripotent Stem Cells
13:18

Generation of Human Cardiomyocytes: A Differentiation Protocol from Feeder-free Human Induced Pluripotent Stem Cells

Published on: June 28, 2013

Related Experiment Videos

Last Updated: May 31, 2026

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells
08:52

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells

Published on: June 13, 2018

Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery
12:40

Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery

Published on: May 19, 2018

Generation of Human Cardiomyocytes: A Differentiation Protocol from Feeder-free Human Induced Pluripotent Stem Cells
13:18

Generation of Human Cardiomyocytes: A Differentiation Protocol from Feeder-free Human Induced Pluripotent Stem Cells

Published on: June 28, 2013

Area of Science:

  • Biomedical research
  • Stem cell biology
  • Disease modeling

Background:

  • Lack of predictive in vitro models hinders understanding of human disease pathophysiology and targeted therapy development.
  • Human induced pluripotent stem (iPS) cells present a promising avenue for creating experimental disease models.
  • Current limitations impede the full realization of iPS cell potential in advancing disease knowledge and therapeutic applications.

Purpose of the Study:

  • To review the current status of human disease modeling using human induced pluripotent stem (iPS) cell lines.
  • To highlight the progress made in replicating various diseases in vitro using iPS cell technology.
  • To identify key challenges and future directions for leveraging iPS cells in disease research and therapy.

Main Methods:

  • Reprogramming of patient somatic cells into induced pluripotent stem (iPS) cells.
  • Directed differentiation of iPS cells into disease-relevant cell types and tissues.
  • In vitro cultivation and experimental manipulation of iPS cell-derived disease models.

Main Results:

  • Successful modeling of diverse conditions including neurodegenerative diseases, hematologic disorders, metabolic diseases, and cardiovascular pathologies.
  • Demonstration of iPS cells' capability to recapitulate key aspects of human diseases in a laboratory setting.
  • Identification of specific cell types and tissues relevant to various pathologies that can be generated from iPS cells.

Conclusions:

  • Human iPS cells provide valuable in vitro models for studying disease mechanisms.
  • Advancements in differentiation protocols are crucial for generating specialized, disease-affected cells.
  • Integrated strategies for drug discovery and cell transplantation are necessary to translate iPS cell research into clinical therapies.